We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+25.08%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.97B
AUM Growth
+$1.75B
(+28%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
26.82%
Holding
643
New
25
Increased
368
Reduced
201
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$64.9M |
| 2 |
Microsoft
MSFT
|
+$13.9M |
| 3 |
Amazon
AMZN
|
+$11.6M |
| 4 |
AbbVie
ABBV
|
+$9.54M |
| 5 |
Illinois Tool Works
ITW
|
+$8.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$19.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$16.2M |
| 3 |
Eli Lilly
LLY
|
+$13M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$5.8M |
| 5 |
Bank of America
BAC
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.9% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Communication Services | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Weyerhaeuser
WY
$18.5B
| $2.97M | 0.04% |
132,152
+2,681
| +2% | +$54.3K |
|
452
Occidental Petroleum
OXY
$56.1B
| $2.96M | 0.04% |
161,936
-800
| -0.5% | -$12.6K |
|
453
Dynatrace
DT
$14.2B
| $2.94M | 0.04% |
+72,500
| New | +$2.39M |
|
454
JB Hunt Transport Services
JBHT
$25.2B
| $2.94M | 0.04% |
24,426
+3,478
| +17% | +$375K |
|
455
Henry Schein
HSIC
$9.82B
| $2.93M | 0.04% |
50,198
+2,504
| +5% | +$140K |
|
456
Dentsply Sirona
XRAY
$2.43B
| $2.92M | 0.04% |
66,193
-3,000
| -4% | -$127K |
|
457
Avantor
AVTR
$9.12B
| $2.91M | 0.04% |
+171,100
| New | +$2.79M |
|
458
Akamai
AKAM
$16.6B
| $2.91M | 0.04% |
27,147
+1,500
| +6% | +$151K |
|
459
Tyson Foods
TSN
$20.6B
| $2.9M | 0.04% |
48,493
+1,500
| +3% | +$90.9K |
|
|
MXIM
460
DELISTED
Maxim Integrated Products
MXIM
| $2.87M | 0.04% |
47,379
+3,000
| +7% | +$167K |
|
|
CDK
461
DELISTED
CDK Global, Inc.
CDK
| $2.86M | 0.04% |
69,012
-3,200
| -4% | -$123K |
|
462
Axalta
AXTA
$8.16B
| $2.86M | 0.04% |
126,642
+40,800
| +48% | +$835K |
|
463
Ingersoll Rand
IR
$34.2B
| $2.85M | 0.04% |
101,469
+32,931
| +48% | +$930K |
|
464
BorgWarner
BWA
$14B
| $2.85M | 0.04% |
91,794
+28,740
| +46% | +$757K |
|
465
Cboe Global Markets
CBOE
$30.3B
| $2.84M | 0.04% |
30,487
+8,600
| +39% | +$847K |
|
466
DaVita
DVA
$11.5B
| $2.84M | 0.04% |
35,917
+4,300
| +14% | +$336K |
|
467
Cummins
CMI
$88.2B
| $2.83M | 0.04% |
16,335
+5,300
| +48% | +$847K |
|
|
FITB
468
Fifth Third Bancorp
FITB
$51.8B
| $2.82M | 0.04% |
146,255
-28,303
| -16% | -$524K |
|
469
Raymond James Financial
RJF
$34.1B
| $2.81M | 0.04% |
61,266
-2,700
| -4% | -$122K |
|
470
Ionis Pharmaceuticals
IONS
$9.2B
| $2.79M | 0.04% |
47,400
-1,900
| -4% | -$106K |
|
471
International Flavors & Fragrances
IFF
$21.6B
| $2.79M | 0.04% |
22,740
-7,676
| -25% | -$970K |
|
472
Albemarle
ALB
$15.2B
| $2.76M | 0.03% |
35,796
+400
| +1% | +$27.2K |
|
473
Zillow
Z
$7.56B
| $2.75M | 0.03% |
47,741
-8,400
| -15% | -$417K |
|
474
Pentair
PNR
$11.2B
| $2.73M | 0.03% |
71,940
-1,000
| -1% | -$35.2K |
|
475
Franklin Resources
BEN
$17B
| $2.71M | 0.03% |
129,011
-58,600
| -31% | -$1.11M |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q2 2020 Portfolio in Review
As of Q2 2020, Fjarde Ap-fonden held 643 positions worth $7.97B, up 28% from $6.21B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fjarde Ap-fonden deployed $349M of net new capital in Q2 2020, opening 25 new positions and adding to 368 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $19.6M trimmed.
- Fjarde Ap-fonden's largest Q2 2020 buy was iShares MSCI USA Value Factor ETF: 931,000 shares worth $67.3M.
- Fjarde Ap-fonden added most to Microsoft in Q2 2020, an estimated $13.9M increase.
- Fjarde Ap-fonden's biggest Q2 2020 reduction was ExxonMobil, cutting an estimated $19.6M.
- Fjarde Ap-fonden fully exited Allergan plc in Q2 2020, selling an estimated $16.2M.
- Fjarde Ap-fonden's ten largest holdings make up 27% of its $7.97B portfolio in Q2 2020.
- Fjarde Ap-fonden opened 25 new positions and closed 37 in Q2 2020.
- Fjarde Ap-fonden's portfolio value rose 28% quarter-over-quarter to $7.97B.
Based on Fjarde Ap-fonden's 13F filing for Q2 2020, filed 13 Aug 2020.